Insulin is the only treatment available for type 1 diabetes mellitus, but due to the low prevalence of this disease, we can consider that consumption fluctuations for this drug are essentially related to type 2 diabetes mellitus. The consumption of noninsulin medicines is related to the treatment of type 2 diabetes mellitus. The gene discussed is INS; the disease is type 2 diabetes mellitus.